Subtype
Spinal Cord Neoplasm
CI-CAN-00001540Explore in graph →
Non-malignant7 active trials1 evidence items
Loading cancer entity…
Subtype
CI-CAN-00001540Explore in graph →
Clinical trials
54 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07225491 | Spine Oncology Registry | recruiting | — | 3,000 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Sep 24, 2026 | clinicaltrials |
| NCT06357377 | A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors | recruiting | Phase 1 | 12 | Neonc Technologies, Inc.INDUSTRY | 1 | Sep 15, 2026 | clinicaltrials |
| NCT04732065 | ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors(PNOC023) | recruiting | Phase 1 | 208 | Sabine Mueller, MD, PhDOTHER | 3 | Jun 11, 2026 | clinicaltrials |
| NCT05023772 |
Data updated 5 days agoSource updated Sep 24, 2026source: clinicaltrials
| recruiting |
| N/A |
| 60 |
| Henry Ford Health SystemOTHER |
| 1 |
| Jun 3, 2026 |
| clinicaltrials |
| NCT05957679 | MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment | recruiting | N/A | 20 | Shengjing HospitalOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07224451 | Liquid Biopsy Following BBB Disruption Using Barrier Disrupting Fields in Patients Undergoing Spine Surgery(BDF002) | recruiting | N/A | 20 | Sheba Medical CenterOTHER_GOV | 1 | Nov 4, 2025 | clinicaltrials |
| NCT07066475 | A Registry-Based Cohort Study on the Clinical Outcomes of Spinal Cord Glioma Resection Via the Dorsolateral Sulcus Approach(DLS) | recruiting | — | 100 | Beijing Tiantan HospitalOTHER | 1 | Jul 23, 2025 | clinicaltrials |
| NCT06869746 | Swiss Spinal Tumor Registry (Swiss-STR)(SSTR) | recruiting | — | 250 | Luzerner KantonsspitalOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06613295 | Separation Surgery Followed by Stereotactic Ablative Body Radiotherapy (SABR) Versus SABR Alone for Spinal Metastases(SABR-MESCC) | recruiting | N/A | 128 | Cancer Research AntwerpOTHER | 1 | Sep 25, 2024 | clinicaltrials |
| NCT06587022 | Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors(ST-SBRT) | recruiting | — | 500 | Peking University Third HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |